Cited by 185Gastrointestinal motility and disordersPain Mechanisms and TreatmentsReceptor Mechanisms and Signaling

Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome

Open access
Jimenez-Vargas, Nestor N., Pattison, Luke A., Zhao, Peishen, Lieu, TinaMarie, Latorre, Rocco, Jensen, Dane D., Castro, Joel, Aurelio, Luigi +19 more·2018·Proceedings of the National Academy of Sciences

Abstract

Significance: Activated G protein-coupled receptors (GPCRs) internalize and can continue to signal from endosomes. The contribution of endosomal signaling to human disease is unknown. Proteases that are generated in the colon of patients with irritable bowel syndrome (IBS) can cleave protease-activated receptor-2 (PAR 2 ) on nociceptors to cause pain. We evaluated whether PAR 2 generates signals in endosomes of nociceptors that mediate persistent hyperexcitability and pain. Biopsies of colonic mucosa from IBS patients released proteases that induced PAR 2 endocytosis, endosomal signaling, and persistent hyperexcitability of nociceptors. When conjugated to the transmembrane lipid cholestanol, PAR 2 antagonists accumulated in endosomes and suppressed persistent hyperexcitability. The results reveal the therapeutic potential of endosomally targeted PAR 2 antagonists for IBS pain, and expand the contribution of endosomal GPCR signaling to encompass processes that are relevant to disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1721891115

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PARs have been implicated in the pathogenesis of colorectal cancer and inflammatory and functional intestinal disorders.

    “PARs have been implicated in the pathogenesis of colorectal cancer138 and inflammatory and functional intestinal disorders.139–141”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jimenez-Vargas, N. N., Pattison, L. A., Zhao, P., Lieu, T., Latorre, R., Jensen, D. D., Castro, J., Aurelio, L., Le, G. T., Flynn, B., Herenbrink, C. K., Yeatman, H. R., Edgington-Mitchell, L., Porter, C. J. H., Halls, M. L., Canals, M., Veldhuis, N. A., Poole, D. P., McLean, P., Hicks, G. A., Scheff, N., Chen, E., Bhattacharya, A., Schmidt, B. L., Brierley, S. M., Vanner, S. J., & Bunnett, N. W.
Affiliations
  • Gastrointestinal Diseases Research Unit, Division of Gastroenterology, Queen’s University, Kingston, ON K7L 2V7, Canada;
  • Australian Research Council (AU)
  • Columbia University (US)
  • Flinders University (AU)
  • Monash Institute of Pharmaceutical Sciences and Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash University, Parkville, VIC 3052, Australia;
  • Takeda (United States) (US)
  • New York University (US)
  • Queen's University (CA)
Venue
Proceedings of the National Academy of Sciences
Published
2018-07-16
Volume
115
Issue
31
Pages
E7438-E7447
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2883889243
Cited by
185
References
46
Citations by year
2026: 16 · 2025: 14 · 2024: 23 · 2023: 28 · 2022: 25 · 2021: 25 · 2020: 25 · 2019: 22 · 2018: 6
FWCI
19.06
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Monash University Research Portal (Monash University) (submittedVersion, other-oa)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
  • Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
  • Repository@Nottingham (University of Nottingham) (submittedVersion)
Funders
  • HHS | NIH | National Institute of Neurological Disorders and Stroke (NS102722)
  • HHS | NIH | National Institute of Dental and Craniofacial Research (DE026806)
  • Department of Health | National Health and Medical Research Council (63303, 1061687, 1126378)
  • Australian Research Council (CE140100036)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
protease-activated receptor 2, endosomal signaling, irritable bowel syndrome, visceral pain, nociceptors, G protein-coupled receptor internalization, endocytosis, PAR2 antagonists, cholestanol
MeSH terms
Animals, Endocytosis, Humans, Nociceptors, Endosomes, Trypsin, Signal Transduction, Irritable Bowel Syndrome, Receptor, PAR-2, Extracellular Signal-Regulated MAP Kinases, Nociception, Chronic Pain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review